Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2012-001596-36-ES
EUCTR2012-001596-36-ES
Active, not recruiting
Not Applicable

Application of Mesenchymal Stem Cells and full of plasma in the management of the burn wound in patients with large burn injury - Stem Cells

MIGUEL CASARES FERNÁNDEZ-ALVÉS0 sitesApril 26, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Sponsor
MIGUEL CASARES FERNÁNDEZ-ALVÉS
Status
Active, not recruiting
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 26, 2012
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
MIGUEL CASARES FERNÁNDEZ-ALVÉS

Eligibility Criteria

Inclusion Criteria

  • •Pacientes que ingresen en el Servicio de Cirugía Plástica del HUG que cumplan las siguientes condiciones:
  • •\- Pacientes mayores de 18 años.
  • •\- Con quemaduras dérmicas totales que requieran injertos mallados 3x1, según valoración del Cirujano Plástico.
  • •\- Que acepten participar en el estudio tras recibir la información adecuada.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 23
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- Pacientes que así lo soliciten.
  • •\- Pacientes en los que, por cualquier motivo (contaminación de la biopsia, problemas técnicos, muerte celular), no se consiga el volumen celular adecuado o no se disponga del medicamento en el momento de la intervención.
  • •\- Pacientes con deterioro hemodinámico o clínico severo (Infección, Sepsis).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Cell therapy with use of mesenchymal stem cells in infertile women with Thin Endometrium
IRCT20230222057500N1Tehran University of Medical Sciences10
Active, not recruiting
Phase 1
Clinical research using the mesenchymal stem cells from autologous fat tissue of Alzheimer dementia
JPRN-jRCTb050190035OOYAMA TAKAYUKI3
Active, not recruiting
Phase 1
The utilization of mesenchymal stem cells (MSC) for the treatment of graft versus host disease (GVHD) after allogeneic stem cell transplantation.The study is intended for patients after allogeneic hematopoietic stem cell transplantation (from related and unrelated donors) with steroid-refractory or steroid-dependent GVHD of any type: - Steroid refractory acute GVHD grade II-IV - Steroid refractory chronic GVHD - Steroid-dependent chronic late onset acute GVHD or overlap GVHDTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2013-003626-88-CZFakultní nemocnice Plzen25
Active, not recruiting
Phase 1
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II study
EUCTR2007-004310-14-BECHU-ULG120
Withdrawn
Phase 2
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II studymesenchymale stamcellen bij acute GvHD of onvoldoende functionerende greffeacute GvHDrejection1002432410018865
NL-OMON31471Academisch Ziekenhuis Maastricht10